Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?

Published: 20 Apr 2019 | Version 1 | DOI: 10.17632/244jnv2vjt.1
Contributor(s):

Description of this data

Chemotherapy guidelines with data extracted from the Australian EviQ Cancer treatment database

Experiment data files

Download all files (1)

This data is associated with the following publication:

Platinum drugs in the Australian cancer chemotherapy healthcare setting: Is it worthwhile for chemists to continue to develop platinums?

Published in: Inorganica Chimica Acta

Latest version

  • Version 1

    2019-04-20

    Published: 2019-04-20

    DOI: 10.17632/244jnv2vjt.1

    Cite this dataset

    Wheate, Nial; Armstrong-Gordon, Evangeline; Um, Irene; Gnjidic, Danijela; Moussa, Yvonne (2019), “Data for: Platinum drugs in the Australian cancer chemotherapy healthcare setting: is it worthwhile for chemists to continue to develop platinums?”, Mendeley Data, v1 http://dx.doi.org/10.17632/244jnv2vjt.1

Statistics

Views: 114
Downloads: 7

Categories

Cancer, Chemotherapy

Licence

CC BY NC 3.0 Learn more

The files associated with this dataset are licensed under a Attribution-NonCommercial 3.0 Unported licence.

What does this mean?
You are free to adapt, copy or redistribute the material, providing you attribute appropriately and do not use the material for commercial purposes.
Read more

Report